# APOBEC3G

## Overview
APOBEC3G is a gene that encodes the protein apolipoprotein B mRNA editing enzyme catalytic subunit 3G, a member of the cytidine deaminase family. This protein plays a pivotal role in the innate immune response, particularly in the defense against retroviruses such as HIV-1. It functions by catalyzing the deamination of cytosine to uracil in single-stranded DNA, leading to hypermutations that impair viral replication. Structurally, APOBEC3G contains two zinc-coordinating domains, with the C-terminal domain being catalytically active. The protein's ability to interact with both viral and host nucleic acids, as well as its capacity to form oligomeric structures, is crucial for its antiviral activity. Beyond its role in viral restriction, APOBEC3G is also implicated in cancer, where its overexpression is associated with poor prognosis in certain types, such as pancreatic adenocarcinoma (Maiti2020Crystal; Harris2015APOBECs; Duan2022Prognostic).

## Structure
APOBEC3G is a member of the APOBEC3 family, characterized by its two zinc-coordinating domains: the N-terminal domain (A3G-NTD) and the C-terminal domain (A3G-CTD). The A3G-NTD is catalytically inactive but essential for encapsidation and interaction with viral and host RNAs, while the A3G-CTD is catalytically active, containing a zinc-binding motif crucial for deamination activity (Maiti2020Crystal). 

The protein's secondary structure includes a five-stranded β-sheet core surrounded by six α-helices, a common feature among deaminase structures (Holden2008Crystal). The active site of the A3G-CTD includes a zinc atom coordinated by specific residues, essential for its deamination function (Holden2008Crystal). 

APOBEC3G can form dimeric and oligomeric structures, although monomeric forms are more catalytically active (Maiti2020Crystal). The protein exhibits dynamic structural transitions between compact globular and extended dumbbell-like forms, facilitated by a flexible linker between the NTD and CTD (Gorle2017Computational). These structural dynamics are crucial for its function in antiviral defense, including its role in viral RNA packaging (Gorle2017Computational).

## Function
APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) is a cytidine deaminase enzyme that plays a crucial role in the innate immune response by targeting viral pathogens, particularly retroviruses like HIV-1. It functions by deaminating cytosine to uracil in single-stranded DNA (ssDNA), leading to G-to-A hypermutations in the viral genome. This mutagenic activity impedes reverse transcription and reduces viral infectivity, effectively inhibiting viral replication (Harris2015APOBECs; Imahashi2012Antiviral).

APOBEC3G is active in both the cytoplasm and nucleus of cells, where it contributes to antiviral defense and maintains genomic integrity. The protein is incorporated into the cores of progeny virions, a location essential for its antiviral activity (Rose2004Transcriptional). Structurally, APOBEC3G contains two cytidine deaminase domains, with the carboxy-terminal domain responsible for its enzymatic activity and the amino-terminal domain involved in binding to nucleic acids and viral proteins (Gooch2008Functional).

The protein's activity is regulated by a protein kinase cascade involving PKCα/βI, MEK, and ERK, which can be activated by extracellular signals such as phorbol myristate acetate (PMA) (Rose2004Transcriptional). This regulation is crucial as overexpression of APOBEC3G can lead to mutagenesis and cellular toxicity.

## Clinical Significance
APOBEC3G is implicated in several diseases and conditions due to its role in viral restriction and genomic stability. In the context of HIV-1 infection, variations in the APOBEC3G gene can influence disease progression. For instance, the rs8177832 (H186R) variant is associated with high viral loads and low CD4 T-cell counts, indicating a potential impact on HIV-1 disease severity (Sadeghpour2021Human). Additionally, APOBEC3G expression levels are linked to clinical outcomes in HIV-1 patients, with higher mRNA levels correlating with lower viremia and higher CD4+ cell counts, suggesting a protective effect (Albin2010Interactions).

In cancer, particularly pancreatic adenocarcinoma (PAAD), APOBEC3G is often overexpressed, which is associated with poor prognosis and aggressive tumor characteristics. This overexpression is linked to gene amplification and is correlated with increased invasion and higher N stage in PAAD patients (Duan2022Prognostic). APOBEC3G's role in cancer is further highlighted by its involvement in immune activation pathways and its potential to contribute to genomic instability, leading to oncogenesis (Duan2022Prognostic). These findings suggest that APOBEC3G may serve as a prognostic marker and therapeutic target in both viral infections and cancer.

## Interactions
APOBEC3G (A3G) is a cytidine deaminase that interacts with various proteins and nucleic acids, playing a significant role in antiviral defense. A3G binds to single-stranded DNA (ssDNA) and RNA, forming complexes that are crucial for its function. The protein's interaction with RNA is particularly important, as RNA binding can inhibit A3G's deaminase activity by displacing ssDNA substrates, leading to the disassembly of functional deaminase complexes (Smith2016RNA; Polevoda2015RNA).

A3G oligomerizes in an RNA-dependent manner, which is essential for its antiviral activity against HIV-1. This oligomerization involves specific residues in the N-terminal cytidine deaminase domain and is necessary for packaging A3G into HIV-1 virions (Huthoff2009RNADependent). A3G also interacts with the HIV-1 nucleocapsid protein NCp7, inhibiting the annealing of tRNA 3 Lys to viral RNA, a critical step for reverse transcription (Guo2007The).

The protein forms ribonucleoprotein complexes with various cellular RNAs, including Y1, Y4, and 7SL RNAs, which are important for its antiviral function (Huthoff2009RNADependent; GalloisMontbrun2008Comparison). These interactions highlight A3G's multifaceted role in cellular and viral processes.


## References


[1. (Gorle2017Computational) Suresh Gorle, Yangang Pan, Zhiqiang Sun, Luda S. Shlyakhtenko, Reuben S. Harris, Yuri L. Lyubchenko, and Lela Vuković. Computational model and dynamics of monomeric full-length apobec3g. ACS Central Science, 3(11):1180–1188, October 2017. URL: http://dx.doi.org/10.1021/acscentsci.7b00346, doi:10.1021/acscentsci.7b00346. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/acscentsci.7b00346)

[2. (Sadeghpour2021Human) Shiva Sadeghpour, Saeideh Khodaee, Mostafa Rahnama, Hamzeh Rahimi, and Diako Ebrahimi. Human apobec3 variations and viral infection. Viruses, 13(7):1366, July 2021. URL: http://dx.doi.org/10.3390/v13071366, doi:10.3390/v13071366. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/v13071366)

[3. (Harris2015APOBECs) Reuben S. Harris and Jaquelin P. Dudley. Apobecs and virus restriction. Virology, 479–480:131–145, May 2015. URL: http://dx.doi.org/10.1016/j.virol.2015.03.012, doi:10.1016/j.virol.2015.03.012. This article has 445 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.virol.2015.03.012)

[4. (Duan2022Prognostic) Yunjie Duan, Yongxing Du, Zongting Gu, Xiaohao Zheng, and Chengfeng Wang. Prognostic value, immune signature and molecular mechanisms of the apobec family members apobec1, apobec3a, apobec3g and apobec3h in pancreatic adenocarcinoma. Frontiers in Molecular Biosciences, October 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.1036287, doi:10.3389/fmolb.2022.1036287. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.1036287)

[5. (Polevoda2015RNA) Bogdan Polevoda, William M. McDougall, Bradley N. Tun, Michael Cheung, Jason D. Salter, Alan E. Friedman, and Harold C. Smith. Rna binding to apobec3g induces the disassembly of functional deaminase complexes by displacing single-stranded dna substrates. Nucleic Acids Research, 43(19):9434–9445, September 2015. URL: http://dx.doi.org/10.1093/nar/gkv970, doi:10.1093/nar/gkv970. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkv970)

[6. (Rose2004Transcriptional) Kristine M. Rose, Mariana Marin, Susan L. Kozak, and David Kabat. Transcriptional regulation of apobec3g, a cytidine deaminase that hypermutates human immunodeficiency virus. Journal of Biological Chemistry, 279(40):41744–41749, October 2004. URL: http://dx.doi.org/10.1074/JBC.M406760200, doi:10.1074/jbc.m406760200. This article has 108 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M406760200)

[7. (Guo2007The) Fei Guo, Shan Cen, Meijuan Niu, Yiliang Yang, Robert J. Gorelick, and Lawrence Kleiman. The interaction of apobec3g with human immunodeficiency virus type 1 nucleocapsid inhibits trna 3 lys annealing to viral rna. Journal of Virology, 81(20):11322–11331, October 2007. URL: http://dx.doi.org/10.1128/jvi.00162-07, doi:10.1128/jvi.00162-07. This article has 100 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00162-07)

[8. (Albin2010Interactions) John S. Albin and Reuben S. Harris. Interactions of host apobec3 restriction factors with hiv-1 in vivo: implications for therapeutics. Expert Reviews in Molecular Medicine, January 2010. URL: http://dx.doi.org/10.1017/s1462399409001343, doi:10.1017/s1462399409001343. This article has 158 citations and is from a peer-reviewed journal.](https://doi.org/10.1017/s1462399409001343)

[9. (Holden2008Crystal) Lauren G. Holden, Courtney Prochnow, Y. Paul Chang, Ronda Bransteitter, Linda Chelico, Udayaditya Sen, Raymond C. Stevens, Myron F. Goodman, and Xiaojiang S. Chen. Crystal structure of the anti-viral apobec3g catalytic domain and functional implications. Nature, 456(7218):121–124, October 2008. URL: http://dx.doi.org/10.1038/nature07357, doi:10.1038/nature07357. This article has 193 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature07357)

[10. (Maiti2020Crystal) Atanu Maiti, Wazo Myint, Krista A. Delviks-Frankenberry, Shurong Hou, Tapan Kanai, Vanivilasini Balachandran, Christina Sierra Rodriguez, Rashmi Tripathi, Nese Kurt Yilmaz, Vinay K. Pathak, Celia A. Schiffer, and Hiroshi Matsuo. Crystal structure of a soluble apobec3g variant suggests ssdna to bind in a channel that extends between the two domains. Journal of Molecular Biology, 432(23):6042–6060, November 2020. URL: http://dx.doi.org/10.1016/j.jmb.2020.10.020, doi:10.1016/j.jmb.2020.10.020. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2020.10.020)

[11. (Smith2016RNA) Harold C. Smith. Rna binding to apobec deaminases; not simply a substrate for c to u editing. RNA Biology, 14(9):1153–1165, December 2016. URL: http://dx.doi.org/10.1080/15476286.2016.1259783, doi:10.1080/15476286.2016.1259783. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15476286.2016.1259783)

[12. (Huthoff2009RNADependent) Hendrik Huthoff, Flavia Autore, Sarah Gallois-Montbrun, Franca Fraternali, and Michael H. Malim. Rna-dependent oligomerization of apobec3g is required for restriction of hiv-1. PLoS Pathogens, 5(3):e1000330, March 2009. URL: http://dx.doi.org/10.1371/journal.ppat.1000330, doi:10.1371/journal.ppat.1000330. This article has 145 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1000330)

[13. (GalloisMontbrun2008Comparison) Sarah Gallois-Montbrun, Rebecca K. Holmes, Chad M. Swanson, Mireia Fernández-Ocaña, Helen L. Byers, Malcolm A. Ward, and Michael H. Malim. Comparison of cellular ribonucleoprotein complexes associated with the apobec3f and apobec3g antiviral proteins. Journal of Virology, 82(11):5636–5642, June 2008. URL: http://dx.doi.org/10.1128/jvi.00287-08, doi:10.1128/jvi.00287-08. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00287-08)

[14. (Gooch2008Functional) Barry D. Gooch and Bryan R. Cullen. Functional domain organization of human apobec3g. Virology, 379(1):118–124, September 2008. URL: http://dx.doi.org/10.1016/j.virol.2008.06.013, doi:10.1016/j.virol.2008.06.013. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.virol.2008.06.013)

[15. (Imahashi2012Antiviral) Mayumi Imahashi, Masaaki Nakashima, and Yasumasa Iwatani. Antiviral mechanism and biochemical basis of the human apobec3 family. Frontiers in Microbiology, 2012. URL: http://dx.doi.org/10.3389/fmicb.2012.00250, doi:10.3389/fmicb.2012.00250. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmicb.2012.00250)